United Kingdom

People: Texas Instruments Inc (TXN.O)

TXN.O on Nasdaq

13 Sep 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cox, Carrie 

Ms. Carrie S. Cox is Independent Director of Texas Instruments Incorporated. Ms. Cox has gained first-hand experience managing large, multinational organizations focused on medical-related markets, with responsibility for those organizations’ financial performance and significant capital and R&D investments, as chairman (2013-present), CEO (2010-2018) and a director (2010-present) of Humacyte, Inc., executive vice president and president of Global Pharmaceuticals at Schering-Plough Corporation (2003-2009) and executive vice president and president of Global Prescription Business at Pharmacia Corporation (1997-2003). Ms. Cox is also a chairman of the board of Array BioPharma, Inc. (2018-present) and ElectroCore, Inc. (2018-present) and a director of Cardinal Health, Inc. (2009-present) and Celgene Corporation (2009-present).

Basic Compensation

Total Annual Compensation, USD 85,000
Restricted Stock Award, USD 99,906
Long-Term Incentive Plans, USD --
All Other, USD 115,374
Fiscal Year Total, USD 300,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --